UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Complementarity between randomised controlled trials and observational registries : the example of cardiovascular prevention with SGLT2 inhibitors

Revue médicale de Liège, 2017-12, Vol.72 (12), p.563

2017

Volltextzugriff (PDF)

STRENGTHS AND WEAKNESSES OF RANDOMISED CLINICAL TRIALS: EVOLVING CHANGES ACCORDING TO PERSONALIZED MEDICINE

Revue médicale de Liège, 2015-05, Vol.70 (5-6), p.232

2015

Volltextzugriff (PDF)

Fructose utilization during exercise in men: rapid conversion of ingested fructose to circulating glucose

Journal of applied physiology (1985), 1993-05, Vol.74 (5), p.2146-2154

1993

Volltextzugriff (PDF)

How I explore ... a risk difference in the occurrence of an event in clinical trials

Revue médicale de Liège, 2012-11, Vol.67 (11), p.597

2012

Volltextzugriff (PDF)

Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism

Fertility and sterility, 1993-04, Vol.59 (4), p.797-802

1993

Volltextzugriff (PDF)

Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: A one-year randomized, prospective, comparative trial

AM. J. OBSTET. GYNECOL. Vol. 163, no. 1. 1990, 1990-07, Vol.163 (1), p.378-381

1990

Volltextzugriff (PDF)

Effect of osmolality on availability of glucose ingested during prolonged exercise in humans

Journal of applied physiology (1985), 1989-07, Vol.67 (1), p.76-82

1989

Volltextzugriff (PDF)

Renal SGLT2 inhibitors, new agents for the management of type 2 diabetes

Revue médicale suisse, 2011-08, Vol.7 (306), p.1621

2011

Volltextzugriff (PDF)

Strategies avoiding inertia and non compliance in clinical trials

Revue médicale de Liège, 2010-05, Vol.65 (5-6), p.246

2010

Volltextzugriff (PDF)

Remarkable metabolic availability of oral glucose during long-duration exercise in humans

Journal of applied physiology (1985), 1986-03, Vol.60 (3), p.1035-1042

1986

Volltextzugriff (PDF)

Optimisation of pharmacological therapy in a patient with a newly diagnosed type 2 diabetes

Revue médicale de Liège, 2009-02, Vol.64 (2), p.109

2009

Volltextzugriff (PDF)

Availability of glucose ingested during muscle exercise performed under acipimox-induced lipolysis blockade

European Journal of Applied Physiology and Occupational Physiology, 1994, Vol.68 (5), p.406-412

1994

Volltextzugriff (PDF)

Blood glucose control and cardiovascular disease in patients with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials

Revue médicale de Liège, 2008-07, Vol.63 (7-8), p.511

2008

Volltextzugriff (PDF)

Endogenous substrate oxidation during exercise and variations in breath 13CO2/12CO2

Journal of applied physiology (1985), 1993-01, Vol.74 (1), p.133-138

1993

Volltextzugriff (PDF)

Metabolic availability of glucose ingested 3 h before prolonged exercise in humans

Journal of applied physiology (1985), 1984-05, Vol.56 (5), p.1314-1319

1984

Volltextzugriff (PDF)

U-100 insulin gives some protection against metabolic deterioration due to CSII interruption

Diabetes care, 1987-11, Vol.10 (6), p.707-711

1987

Volltextzugriff (PDF)

Utilization of oral sucrose load during exercise in humans. Effect of the alpha-glucosidase inhibitor acarbose

Diabetes (New York, N.Y.), 1986-11, Vol.35 (11), p.1294-1301

1986

Volltextzugriff (PDF)

Treatment of obesity: are drug combinations effective?

Journal de pharmacie de Belgique, 1996-07, Vol.51 (4), p.228

Jandrain, B

1996

Volltextzugriff (PDF)

Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII

Diabetes care, 1987-09, Vol.10 (5), p.567-572

1987

Volltextzugriff (PDF)

Brain, a gluco-dependent organ: toxic effects of hypoglycaemia and hyperglycaemia

Revue médicale de Liège, 2008-05, Vol.63 (5-6), p.280

2008

Volltextzugriff (PDF)

Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in Type 1 (insulin-dependent) diabetic patients

Diabetologia, 1989-11, Vol.32 (11), p.801-809

1989

Volltextzugriff (PDF)

Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion

Diabetes care, 1984-07, Vol.7 (4), p.338-342

1984

Volltextzugriff (PDF)

Anti-insulin antibodies and metabolic deterioration after interruption of continuous subcutaneous insulin infusion

Diabetes care, 1986-11, Vol.9 (6), p.673-674

1986

Volltextzugriff (PDF)

Use of 13C substrates for metabolic studies in exercise: methodological considerations

Journal of applied physiology (1985), 1991-11, Vol.71 (5), p.2059-2061

1991

Volltextzugriff (PDF)

How I explore ... the risk of a patient developing type 2 diabetes

Revue médicale de Liège, 2002-02, Vol.57 (2), p.113

2002

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(8)

Publikationsform

Artikel
(51)
Tagungsberichte
(1)

Sprache

Englisch
(26)
Französisch
(26)

Erscheinungsjahr

n.n

Thema

Humans
(47)
Adult
(21)
Male
(19)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Insulin - Blood
(14)
Biological And Medical Sciences
(12)
Blood Glucose - Metabolism
(12)
C-Peptide - Blood
(12)
Endocrinologie, Métabolisme & Nutrition
(11)
Endocrinology, Metabolism & Nutrition
(11)
Female
(11)
Glucose - Metabolism
(11)
Human Health Sciences
(11)
Sciences De La Santé Humaine
(11)
Diabetes Mellitus, Type 1 - Drug Therapy
(9)
Fatty Acids, Nonesterified - Blood
(9)
Medical Sciences
(9)
3-Hydroxybutyric Acid
(7)
Blood Glucose - Analysis
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Complementarity between randomised controlled trials and observational registries : the example of cardiovascular prevention with SGLT2 inhibitors

STRENGTHS AND WEAKNESSES OF RANDOMISED CLINICAL TRIALS: EVOLVING CHANGES ACCORDING TO PERSONALIZED MEDICINE

Fructose utilization during exercise in men: rapid conversion of ingested fructose to circulating glucose

How I explore ... a risk difference in the occurrence of an event in clinical trials

Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism

Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: A one-year randomized, prospective, comparative trial

Effect of osmolality on availability of glucose ingested during prolonged exercise in humans

Renal SGLT2 inhibitors, new agents for the management of type 2 diabetes

Strategies avoiding inertia and non compliance in clinical trials

Remarkable metabolic availability of oral glucose during long-duration exercise in humans

Optimisation of pharmacological therapy in a patient with a newly diagnosed type 2 diabetes

Availability of glucose ingested during muscle exercise performed under acipimox-induced lipolysis blockade

Blood glucose control and cardiovascular disease in patients with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials

Endogenous substrate oxidation during exercise and variations in breath 13CO2/12CO2

Metabolic availability of glucose ingested 3 h before prolonged exercise in humans

U-100 insulin gives some protection against metabolic deterioration due to CSII interruption

Utilization of oral sucrose load during exercise in humans. Effect of the alpha-glucosidase inhibitor acarbose

Treatment of obesity: are drug combinations effective?

Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII

Brain, a gluco-dependent organ: toxic effects of hypoglycaemia and hyperglycaemia

Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in Type 1 (insulin-dependent) diabetic patients

Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion

Anti-insulin antibodies and metabolic deterioration after interruption of continuous subcutaneous insulin infusion

Use of 13C substrates for metabolic studies in exercise: methodological considerations

How I explore ... the risk of a patient developing type 2 diabetes

Suchergebnisse filtern